Peng Xia

7.0k total citations · 1 hit paper
151 papers, 2.7k citations indexed

About

Peng Xia is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Peng Xia has authored 151 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 24 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Peng Xia's work include Liver physiology and pathology (15 papers), RNA modifications and cancer (14 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). Peng Xia is often cited by papers focused on Liver physiology and pathology (15 papers), RNA modifications and cancer (14 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). Peng Xia collaborates with scholars based in China, United States and Germany. Peng Xia's co-authors include Jing Ai, Hao Zhang, Yufeng Yuan, Meiyu Geng, Weijie Ma, Kequan Xu, Gang Pei, Zhaokang Cheng, Yuening Liu and Jingrui Chen and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Peng Xia

142 papers receiving 2.6k citations

Hit Papers

METTL5 stabilizes c‐Myc by facilitating USP5 translation ... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Xia China 28 1.2k 401 333 312 264 151 2.7k
Lizhen Wang China 30 1.2k 1.0× 242 0.6× 530 1.6× 248 0.8× 198 0.8× 219 3.5k
Tan Zhang China 30 1.8k 1.4× 404 1.0× 444 1.3× 300 1.0× 137 0.5× 126 3.6k
Kuo Zhang China 32 1.4k 1.2× 425 1.1× 279 0.8× 533 1.7× 140 0.5× 158 3.3k
Amelia Cataldi Italy 36 1.9k 1.6× 383 1.0× 375 1.1× 628 2.0× 326 1.2× 238 4.5k
Guo‐Tong Xu China 32 1.7k 1.4× 350 0.9× 295 0.9× 170 0.5× 104 0.4× 129 3.5k
Bing Zou China 29 1.2k 1.0× 359 0.9× 563 1.7× 158 0.5× 109 0.4× 117 2.5k
Chun-Chi Liang United States 15 2.0k 1.7× 554 1.4× 596 1.8× 471 1.5× 171 0.6× 17 4.6k
Danyang Chen China 31 1.5k 1.3× 362 0.9× 461 1.4× 418 1.3× 67 0.3× 167 3.7k
Changlong Li China 25 913 0.8× 294 0.7× 222 0.7× 324 1.0× 93 0.4× 112 2.4k

Countries citing papers authored by Peng Xia

Since Specialization
Citations

This map shows the geographic impact of Peng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Xia more than expected).

Fields of papers citing papers by Peng Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Xia. The network helps show where Peng Xia may publish in the future.

Co-authorship network of co-authors of Peng Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Xia. A scholar is included among the top collaborators of Peng Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Xia. Peng Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yuan, Bo, et al.. (2023). Key issues of Development and Utilization of New Energy in China under Carbon Peaking and Carbon Neutrality. SHILAP Revista de lepidopterología. 406. 4047–4047. 1 indexed citations
3.
Xia, Peng, Hao Zhang, Haofeng Lu, et al.. (2023). METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression. Cancer Communications. 43(3). 338–364. 99 indexed citations breakdown →
5.
Zhang, Yunong, Peng Xia, Jian Zou, et al.. (2022). Discovery of 3-Aminopyrazole Derivatives as New Potent and Orally Bioavailable AXL Inhibitors. Journal of Medicinal Chemistry. 65(22). 15374–15390. 15 indexed citations
6.
Kang, Tongtong, et al.. (2022). Review of Flexible Wearable Sensor Devices for Biomedical Application. Micromachines. 13(9). 1395–1395. 58 indexed citations
7.
Xia, Peng, Haitao Yuan, Ming Tian, et al.. (2022). Surface‐Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo‐Photothermal Drugs for Gastric Cancer Theragnostic. Advanced Functional Materials. 33(7). 27 indexed citations
8.
Yang, Shiwen, Mei Wang, Lili Yang, et al.. (2020). MicroRNA-375 Targets ATG14 to Inhibit Autophagy and Sensitize Hepatocellular Carcinoma Cells to Sorafenib. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Liu, Jiajun, Feng Guo, Zhongrui Li, Ren‐Ke Li, & Peng Xia. (2020). Long Non-Coding RNA FEZF1-AS1 Modulates CXCR4 to Promote Cell Proliferation, Warburg Effect and Suppress Cell Apoptosis in Osteosarcoma by Sponging miR-144. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Li, Huijun, Peng Xia, Su Pan, et al.. (2020). The Advances of Ceria Nanoparticles for Biomedical Applications in Orthopaedics. SHILAP Revista de lepidopterología. 2 indexed citations
11.
Sun, Jianbao, Li X, Aimin Chen, et al.. (2019). A Dual-Modality MR/PA Imaging Contrast Agent Based on Ultrasmall Biopolymer Nanoparticles for Orthotopic Hepatocellular Carcinoma Imaging. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Kong, Weijian, Peng Xia, Yuxin Chang, et al.. (2019). Local delivery of FTY720 and NSCs on electrospun PLGA scaffolds improves functional recovery after spinal cord injury. RSC Advances. 9(31). 17801–17811. 17 indexed citations
13.
Wang, Xinyi, Jing Ai, Hongyan Liu, et al.. (2018). The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors. Molecular Cancer Therapeutics. 18(3). 667–679. 11 indexed citations
14.
Jiang, Xiaolong, Ji Zhou, Jing Ai, et al.. (2015). Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: Design, synthesis, and structure—activity relationship study. European Journal of Medicinal Chemistry. 105. 39–56. 15 indexed citations
15.
Jiang, Xiaolong, Hongyan Liu, Zilan Song, et al.. (2014). Discovery and SAR study of c-Met kinase inhibitors bearing an 3-amino-benzo[d]isoxazole or 3-aminoindazole scaffold. Bioorganic & Medicinal Chemistry. 23(3). 564–578. 15 indexed citations
16.
Wang, Lu, Jing Ai, Yanyan Shen, et al.. (2014). SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo. Cancer Letters. 351(1). 143–150. 12 indexed citations
17.
Lei, Na, et al.. (2011). The proper interpolation space for multivariate Birkhoff interpolation. Journal of Computational and Applied Mathematics. 235(10). 3207–3214. 9 indexed citations
18.
Xia, Peng. (2006). NUMERICAL SIMULATION OF STEADY FLOW IN VORTEX PUMP. Journal of Engineering Thermophysics. 5 indexed citations
19.
Li, Jie, et al.. (2002). [Reversal of nomegestrol acetate on multidrug resistance in drug-resistant human breast cancer cell line MCF7/ADR].. PubMed. 24(2). 129–32. 1 indexed citations
20.
Xia, Peng. (1999). The three phase induction motor with noninterupt pole-changing winding. Dianji yu kongzhi xuebao. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026